The University of Southampton
University of Southampton Institutional Repository

COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: a retrospective study in the United Kingdom

COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: a retrospective study in the United Kingdom
COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: a retrospective study in the United Kingdom
Background: comprehensive research about changes in risk factor (RF) management of people with chronic conditions during the COVID-19 pandemic is sparse. We aimed to study the impact of the pandemic on RF assessment in people with type 2 diabetes (T2DM), cardiovascular disease (CVD), and chronic kidney disease (CKD).

Method: using UK Clinical Practice Research Datalink GOLD, we identified adults with T2DM, CVD and CKD who were alive and registered two years before (March 2018 – February 2019; March 2019 – February 2020) and one year during (March 2020 – February 2021) the pandemic. We estimated the proportion of people whose RFs (systolic (SBP) and diastolic (DBP) blood pressure, total cholesterol (TC), body mass index, smoking, and HbA1c) were assessed, mean values, and the proportion of controlled at each period for each cohort, overall and by age, sex, ethnicity, and deprivation. Multivariable logistic regression was used to estimate the association of patient characteristics (age, sex, ethnicity, deprivation, and comorbidity) with the outcome of having all RFs assessed during a given period.

Results: within the T2DM cohort, 66.4% and 65.2% had assessments of HbA1c in 2018 and 2019, which reduced to 43.4% in 2020. In CVD cohort, 76.9% and 72.6% had their BP measurements (54.5% and 51.3% for TC) in 2018 and 2019 respectively, which declined to 40.6% (30.7% for TC) in 2020. In CKD cohort, BP assessments declined from 77.9% and 72.3% in 2018 and 2019 respectively to 45.0% in 2020. These findings were consistent across patient demographics. In those with T2DM, SBP and DBP increased (+1.65 mmHg and +1.02 mmHg) in 2020. Elderly people were less likely to have all their RFs assessed in 2020 in all three cohorts compared to previous years.

Conclusions: among people with major cardiometabolic conditions, there have been substantial reductions in the assessment and control of several key RFs during the pandemic. These patients will need regular monitoring in future for the prevention of complications. Our findings also highlight the need for resilient healthcare systems to ensure continuity of care and mitigate disparities in high-risk populations.
1932-6203
Shabnam, Sharmin
b337b72e-6dc4-4b56-b09a-ba11bc63a657
Zaccardi, Francesco
8d31a980-3db1-4477-9514-c18087cf886a
Yates, Tom
6a3cb2f6-ab68-4729-a105-24983ae2acf0
Islam, Nazrul
e5345196-7479-438f-b4f6-c372d2135586
Razieh, Cameron
1f2cef7c-20b4-4edc-9533-c34fed0bfc13
Chudasama, Yogini V.
4abd13c8-010f-4d0e-8511-801ee4943959
Banerjee, Amitava
1073b76f-0867-4e2a-bc92-22602581db01
Seidu, Samuel
00275417-c5b9-4871-9d8e-478fffd1ec35
Khunti, Kamlesh
3e64e5f4-0cc9-4524-aa98-3c74c25101c3
Gillies, Clare L
fc26555a-79f4-4d0e-9a34-1dc4fbda4be9
Shabnam, Sharmin
b337b72e-6dc4-4b56-b09a-ba11bc63a657
Zaccardi, Francesco
8d31a980-3db1-4477-9514-c18087cf886a
Yates, Tom
6a3cb2f6-ab68-4729-a105-24983ae2acf0
Islam, Nazrul
e5345196-7479-438f-b4f6-c372d2135586
Razieh, Cameron
1f2cef7c-20b4-4edc-9533-c34fed0bfc13
Chudasama, Yogini V.
4abd13c8-010f-4d0e-8511-801ee4943959
Banerjee, Amitava
1073b76f-0867-4e2a-bc92-22602581db01
Seidu, Samuel
00275417-c5b9-4871-9d8e-478fffd1ec35
Khunti, Kamlesh
3e64e5f4-0cc9-4524-aa98-3c74c25101c3
Gillies, Clare L
fc26555a-79f4-4d0e-9a34-1dc4fbda4be9

Shabnam, Sharmin, Zaccardi, Francesco, Yates, Tom, Islam, Nazrul, Razieh, Cameron, Chudasama, Yogini V., Banerjee, Amitava, Seidu, Samuel, Khunti, Kamlesh and Gillies, Clare L (2025) COVID-19 pandemic and risk factor measurement in individuals with cardio-renal-metabolic diseases: a retrospective study in the United Kingdom. PLoS ONE, 20 (4), [e0319438]. (doi:10.1371/journal.pone.0319438).

Record type: Article

Abstract

Background: comprehensive research about changes in risk factor (RF) management of people with chronic conditions during the COVID-19 pandemic is sparse. We aimed to study the impact of the pandemic on RF assessment in people with type 2 diabetes (T2DM), cardiovascular disease (CVD), and chronic kidney disease (CKD).

Method: using UK Clinical Practice Research Datalink GOLD, we identified adults with T2DM, CVD and CKD who were alive and registered two years before (March 2018 – February 2019; March 2019 – February 2020) and one year during (March 2020 – February 2021) the pandemic. We estimated the proportion of people whose RFs (systolic (SBP) and diastolic (DBP) blood pressure, total cholesterol (TC), body mass index, smoking, and HbA1c) were assessed, mean values, and the proportion of controlled at each period for each cohort, overall and by age, sex, ethnicity, and deprivation. Multivariable logistic regression was used to estimate the association of patient characteristics (age, sex, ethnicity, deprivation, and comorbidity) with the outcome of having all RFs assessed during a given period.

Results: within the T2DM cohort, 66.4% and 65.2% had assessments of HbA1c in 2018 and 2019, which reduced to 43.4% in 2020. In CVD cohort, 76.9% and 72.6% had their BP measurements (54.5% and 51.3% for TC) in 2018 and 2019 respectively, which declined to 40.6% (30.7% for TC) in 2020. In CKD cohort, BP assessments declined from 77.9% and 72.3% in 2018 and 2019 respectively to 45.0% in 2020. These findings were consistent across patient demographics. In those with T2DM, SBP and DBP increased (+1.65 mmHg and +1.02 mmHg) in 2020. Elderly people were less likely to have all their RFs assessed in 2020 in all three cohorts compared to previous years.

Conclusions: among people with major cardiometabolic conditions, there have been substantial reductions in the assessment and control of several key RFs during the pandemic. These patients will need regular monitoring in future for the prevention of complications. Our findings also highlight the need for resilient healthcare systems to ensure continuity of care and mitigate disparities in high-risk populations.

Text
journal.pone.0319438 - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 1 February 2025
Published date: 24 April 2025

Identifiers

Local EPrints ID: 505555
URI: http://eprints.soton.ac.uk/id/eprint/505555
ISSN: 1932-6203
PURE UUID: 71e58231-3613-4979-aa0e-d04f4c8a6470
ORCID for Nazrul Islam: ORCID iD orcid.org/0000-0003-3982-4325

Catalogue record

Date deposited: 13 Oct 2025 17:01
Last modified: 14 Oct 2025 02:09

Export record

Altmetrics

Contributors

Author: Sharmin Shabnam
Author: Francesco Zaccardi
Author: Tom Yates
Author: Nazrul Islam ORCID iD
Author: Cameron Razieh
Author: Yogini V. Chudasama
Author: Amitava Banerjee
Author: Samuel Seidu
Author: Kamlesh Khunti
Author: Clare L Gillies

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×